Austin, April 11, 2025 (GLOBE NEWSWIRE) -- According to a new report by SNS Insider, the Nucleic Acid Amplification Testing (NAAT) Market, valued at USD 7.36 billion in 2023, is projected to reach ...

This is done without the need for nucleic acid amplification. In CRISPR/Cas-based diagnostic tests, guide RNAs bind pathogen ...

The incidence of chlamydia and gonorrhea, 2 common sexually transmitted infections, is increasing. Annual asymptomatic screening for chlamydia and gonorrhea should be performed in all sexually active ...

The isothermal nucleic acid amplification technology (INAAT) market value is projected to reach USD 2.8 billion by 2028, according to a new research report by Global Market Insights Inc ...

72 studies had sufficient data for meta-analysis. The team concluded that the nucleic-acid amplification tests (NAAT) is the recommended practice for detecting the toxin gene. GDH/NAAT algorithm ...

NUCLEIC ACID AMPLIFICATION AND DETECTION METHODS developed in the past decade are useful for the diagnosis and management of a variety of infectious diseases. The most widely used of these methods is ...

The patent, titled “Method of Preparing Cell Free Nucleic Acid Molecules by In Situ Amplification,” covers methods for the linear in situ amplification (LISA) of cfNA, such as cell-free DNA ...

to achieve amplification-free detection of pathogenic DNA. Upon target recognition, Cas12a in the T1 complex cleaves blocked nucleic acids, triggering the release of switchable caged RNA that ...